Your organization will owe ILS their 10-20% locator fee as soon as the clinical trial agreement is executed. Further, your site assumes the risk of not covering this cost if the study does not enroll a sufficient number of patients to cover the expense.
-----Original Message-----
From: Research Administration List [mailto:xxxxxx@HRINET.ORG]On Behalf Of Terry Stout
Sent: Friday, April 04, 2003 1:47 PM
To: xxxxxx@HRINET.ORG
Subject: [RESADM-L] Clinical Trial Locator Service

Happy Friday!

Can anyone advise if you are familiar with the following company and have utilized their services:

Investigator Location Services

1280 Bison Street

Suite B9-543

Newport Beach, CA 92660

 

Their expertise lies in matching a pharmaceutical company with a principal investigator. Catch comes in when they charge anywhere

from 10-20% of the total project cost (per patient fee x number of patients) for the service. IlS has approached us on couple deals right now but it doesn't appear the fees generated from the trial will cover their locator fees. Haven't seen their agreement yet so I'm not sure how/when they get their fees in the deal.

 

Thanks to all!

 

 

Terry L. Stout
Director of Industry Relations
Wake Forest University Health Sciences
Medical Center Boulevard
Winston-Salem, NC 27157-1023
(336) 716-9941 Voice
(336) 716-4480 FAX
xxxxxx@wfubmc.edu email
 
 

 

 

 

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================